FR2141M - Médicament a base de triméthobenzamide et de β-pyridyl-carbinol. - Google Patents

Médicament a base de triméthobenzamide et de β-pyridyl-carbinol.

Info

Publication number
FR2141M
FR2141M FR904728A FR904728A FR2141M FR 2141 M FR2141 M FR 2141M FR 904728 A FR904728 A FR 904728A FR 904728 A FR904728 A FR 904728A FR 2141 M FR2141 M FR 2141M
Authority
FR
France
Prior art keywords
trimethobenzamide
carbinol
pyridyl
product based
medicinal product
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR904728A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Application granted granted Critical
Publication of FR2141M publication Critical patent/FR2141M/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
FR904728A 1961-07-27 1962-07-23 Médicament a base de triméthobenzamide et de β-pyridyl-carbinol. Expired FR2141M (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US127150A US3077435A (en) 1961-07-27 1961-07-27 Therapeutic composition comprising 4-(2-dimethylaminoethoxy)-4-(3, 4, 5-trimethoxybenzoyl)-benzylamine and betapyridylcarbinol

Publications (1)

Publication Number Publication Date
FR2141M true FR2141M (fr) 1963-11-12

Family

ID=22428557

Family Applications (1)

Application Number Title Priority Date Filing Date
FR904728A Expired FR2141M (fr) 1961-07-27 1962-07-23 Médicament a base de triméthobenzamide et de β-pyridyl-carbinol.

Country Status (4)

Country Link
US (1) US3077435A (fr)
ES (1) ES279551A1 (fr)
FR (1) FR2141M (fr)
GB (1) GB936068A (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040034102A1 (en) * 2002-02-06 2004-02-19 King Pharmaceuticals, Inc. Oral pediatric trimethobenzamide formulations and methods

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2879293A (en) * 1957-02-19 1959-03-24 Hoffmann La Roche Benzylamine derivatives

Also Published As

Publication number Publication date
ES279551A1 (es) 1963-03-16
US3077435A (en) 1963-02-12
GB936068A (en) 1963-09-04

Similar Documents

Publication Publication Date Title
FR1275M (fr) Médicament a base de colibacilles vivants.
FR1916M (fr) Médicament a base de 16.α-méthyl-6-α-fluoro-1.4-prégnadiene-11.β.21-diol-3.20-dione.
FR1711M (fr) Médicament a base de nouveaux éthers.
FR2094M (fr) Médicament a base d'un nouvel hendécapeptide.
FR1704M (fr) Médicament anti-allergique et anti-histaminique a base de β-alanine.
FR1891M (fr) Médicament a base d'un phénoxy-alcane.
FR2141M (fr) Médicament a base de triméthobenzamide et de β-pyridyl-carbinol.
FR1827M (fr) Médicament a base de 1.5-benzo-dioxépannes.
FR2127M (fr) Médicament a base de dérivé du thiaxanthene.
FR1185M (fr) Médicament a base de colibacilles non pathogenes vivants.
FR2410M (fr) Médicament a base de dérivé de l'oxazine.
FR2231M (fr) Médicament a base de nouvelles dibenzothiéphinnes.
FR2347M (fr) Médicament a base de sulfanilamides.
FR1214M (fr) Médicament a base de β-camphosulfonate de n-méthyl-éphédrine.
FR1504M (fr) Médicament a base de dérivé du thiaxanthene.
FR2093M (fr) Médicament a base de dérivé d'hydroxy-dibenzocycloheptane.
FR2577M (fr) Médicament a base de naphtyl-amino-imidazoline.
FR1144M (fr) Médicament a base de 1.2-diaryl-3.5-dioxo-pyrazolidines.
FR1075M (fr) Médicament a base de 4-nitro-3-hydroxy-thiofene-2-carboxylate de méthyle.
FR1802M (fr) Médicament a base de nouveaux naphtaquinols.
FR2180M (fr) Médicament a base de nouveaux 10-alcényl-stéroides.
FR1947M (fr) Médicament a base de dérivé de thiéno-benzothiopyranne.
FR1268M (fr) Médicament antimitotique et antiviral.
FR2122M (fr) Médicament a base de dérivé du thiaxanthene.
FR1824M (fr) Médicament a base d'amines tertiaires.